You are here: Home / NEWS / Meeting discusses the development of drugs and medicines at USP

Meeting discusses the development of drugs and medicines at USP

by Richard Meckien - published Dec 03, 2015 12:05 PM - - last modified Jun 04, 2019 11:48 AM
Rights: Original version in Portuguese by Fernanda Rezende

The development of drugs and medicines at USP will be the theme of the third strategic workshop of the Dean for Research, which takes place on December 10, from 10 am to 6 pm, in the IEA Events Room. Carried out with IEA's support, the meeting will bring together experts from the university and the private sector.

Divided into thematic modules, the workshop Development of Drugs and Medicines at USP aims, like others of the series of meetings, to stimulate reflection and dialogue around the strategic themes for research at the University of São Paulo. It also seeks to create a scientific and technological environment of collaboration between the USP community and external agents.

The meeting has been organized by Hamilton Varela, advisor to the Dean for Research, professor of the IQSC (Institute of Chemistry in São Carlos) and president of the IEA Research Commission, and Adriano Andricopulo, a professor at the Institute of Physics in São Carlos. The coordinators are Andricopulo, Glaucius Oliva, a professor at the Institute of Physics in São Carlos, and Luiz Catalani, from the Institute of Chemistry. The speakers will be:

  • Adriano Andricopulo (Institute of Physics - USP São Carlos)
  • Glaucius Oliva (Institute of Physics - USP São Carlos)
  • Luiz Catalani (Institute of Chemistry - USP)
  • Jorge Kalil (School of Medicine - USP)
  • Esper Georges Kallás (School of Medicine - USP)
  • Gustavo Kesselring (Brazilian Society of Pharmaceutical Medicine)
  • José Fernando Perez (Biopharma)
  • Reginaldo Arcuri (FarmaBrasil)
  • Célia R. S. Garcia (Institute of Biosciences - USP)
  • Norberto P. Lopes (Faculty of Pharmaceutical Sciences - USP Ribeirão Preto)
  • José Eduardo Krieger (School of Medicine and Dean for Research - USP)
  • Luiz Eduardo Caroli (Biozeus)